Year-end Sale % OFF 
Abstract
We thank Drs. Chahin and Karam for their constructive comments on our article.1 There was no difference in the Neuropathy Impairment Score-Weakness2 at presentation between patients treated with intravenous immunoglobulin (IVIG) and autologous stem cell transplant (ASCT) (median: 27.5 vs 26.25, respectively).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
